申请人:Omeros Corporation
公开号:EP1563838A2
公开(公告)日:2005-08-17
A method and solution for perioperatively inhibiting a variety of pain and inflammation, processes at wounds from general surgical procedures including oral/dental procedures. The solution preferably includes at least one α2- receptor agonist and, optionally, additional multiple pain and inflammation inhibitory agents at dilute concentration in a physiologic carrier, such as saline or lactated Ringer's solution. The solution is applied by continuous irrigation of a wound during a surgical procedure for preemptive inhibition of pain and while avoiding undesirable side effects associated with oral, intramuscular, subcutaneous or intravenous application of larger doses of the agents. One preferred solution to inhibit pain and inflammation, includes an α2- receptor agonist, a serotonin2 antagonist, a serotonin3 antagonist, a histamine antagonist, a serotonin agonist, a cyclooxygenase inhibitor, a neurokinin1 antagonist, a neurokinin2 antagonist, a purinoceptor antagonist, an ATP-sensitive potassium channel opener, a calcium channel antagonist, a bradykinin1 antagonist, a bradykinin2 antagonist and a µ-opioid agonist.
一种围手术期抑制包括口腔/牙科手术在内的一般外科手术伤口处各种疼痛和炎症过程的方法和溶液。该溶液最好包括至少一种α2-受体激动剂,另外还包括在生理载体(如生理盐水或乳酸林格氏液)中稀释浓度的多种疼痛和炎症抑制剂。该溶液可在手术过程中通过持续冲洗伤口来预先抑制疼痛,同时避免口服、肌肉注射、皮下注射或静脉注射大剂量药物所带来的不良副作用。一种优选的抑制疼痛和炎症的方案包括α2 受体激动剂、5-羟色胺2 拮抗剂、5-羟色胺3 拮抗剂、组胺拮抗剂、5-羟色胺激动剂、环氧化酶抑制剂、神经激肽1 拮抗剂、组胺拮抗剂、5-羟色胺激动剂、环氧化酶抑制剂、神经激肽 1 拮抗剂、神经激肽 2 拮抗剂、嘌呤受体拮抗剂、ATP 敏感性钾通道开放剂、钙通道拮抗剂、缓激肽 1 拮抗剂、缓激肽 2 拮抗剂和 µ 阿片类激动剂。